Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Free Cash Flow: -153.27M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -153.27M |
| June 30, 2024 | -130.44M |
| March 31, 2024 | -111.41M |
| December 31, 2023 | -99.74M |
| September 30, 2023 | -87.31M |
| June 30, 2023 | -82.50M |
| March 31, 2023 | -75.84M |
| December 31, 2022 | -64.97M |
| Date | Value |
|---|---|
| September 30, 2022 | -60.15M |
| June 30, 2022 | -53.37M |
| March 31, 2022 | -47.61M |
| December 31, 2021 | -40.00M |
| September 30, 2021 | -31.98M |
| June 30, 2021 | -24.65M |
| March 31, 2021 | -17.89M |
| December 31, 2020 | -14.95M |
Free Cash Flow Range, Past 5 Years
-153.27M
Minimum
Sep 2024
-14.95M
Maximum
Dec 2020
-68.51M
Average
-62.56M
Median
Free Cash Flow Benchmarks
| Viking Therapeutics Inc | -74.25M |
| Bristol-Myers Squibb Co | 13.80B |
| Replimune Group Inc | -188.31M |
| Moderna Inc | -3.956B |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -45.82M |
| Cash from Investing (Quarterly) | -212.91M |
| Cash from Financing (Quarterly) | 550.27M |
| Free Cash Flow Per Share (Quarterly) | -0.6976 |
| Free Cash Flow Yield | -2.75% |